• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.64% Nasdaq Down0.55%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -NYSE MKT
    1.25 Down 0.04(3.10%) May 29, 4:05PM EDT
    |After Hours : 1.25 0.00 (0.00%) May 29, 4:24PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 6,275   1,131   79  
    Cost of Revenue1,586  333   -  
    Gross Profit 4,689   798   79  
    Operating Expenses
    Research Development16,780  23,710  16,890  
    Selling General and Administrative15,542  15,526  11,178  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (27,633) (38,438) (27,989)
    Income from Continuing Operations
    Total Other Income/Expenses Net(3,864)(1,482)(2)
    Earnings Before Interest And Taxes(32,020)(39,921)(27,991)
    Interest Expense3,706  2,779  1,166  
    Income Before Tax(35,727)(42,699)(29,157)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(38,861)(44,072)(29,157)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (35,727) (42,699) (29,157)
    Preferred Stock And Other Adjustments -   -  (43)
    Net Income Applicable To Common Shares (35,727) (42,699) (29,201)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.